{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1142.23","meta":{"versionId":"12","lastUpdated":"2016-09-09T01:00:03.000-04:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>C2S HIV/AIDS Information Sensitivity</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <code>http://www.nlm.nih.gov/research/umls/hcpcs</code>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>0575F</td>\n              <td>Hiv rna control plan of care, documented (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3292F</td>\n              <td>Hiv testing ordered or documented and reviewed during the first or second prenatal visit (pre-cr)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3490F</td>\n              <td>History of aids-defining condition (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3491F</td>\n              <td>Hiv indeterminate (infants of undetermined hiv status born of hiv-infected mothers) (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3492F</td>\n              <td>History of nadir cd4+ cell count &lt;350 cells/mm (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3493F</td>\n              <td>No history of nadir cd4+ cell count &lt;350 cells/mmand no history of aids-defining condition (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3494F</td>\n              <td>Cd4+ cell count &lt;200 cells/mm (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3495F</td>\n              <td>Cd4+ cell count 200 - 499 cells/mm (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3496F</td>\n              <td>Cd4+ cell count =500 cells/mm (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3497F</td>\n              <td>Cd4+ cell percentage &lt;15% (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3498F</td>\n              <td>Cd4+ cell percentage &gt;/=15% (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3500F</td>\n              <td>Cd4+ cell count or cd4+ cell percentage documented as performed (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3502F</td>\n              <td>Hiv rna viral load below limits of quantification (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3503F</td>\n              <td>Hiv rna viral load not below limits of quantification (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3510F</td>\n              <td>Documentation that tuberculosis (tb) screening test performed and results interpreted (hiv) (ibd)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3511F</td>\n              <td>Chlamydia and gonorrhea screenings documented as performed (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3512F</td>\n              <td>Syphilis screening documented as performed (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3513F</td>\n              <td>Hepatitis b screening documented as performed (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3514F</td>\n              <td>Hepatitis c screening documented as performed (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>3515F</td>\n              <td>Patient has documented immunity to hepatitis c (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>4149F</td>\n              <td>Hepatitis b vaccine injection administered or previously received (hep-c, hiv) (ibd)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>4270F</td>\n              <td>Patient receiving potent antiretroviral therapy for 6 months or longer (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>4271F</td>\n              <td>Patient receiving potent antiretroviral therapy for less than 6 months or not receiving potent antiretroviral therapy (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>4274F</td>\n              <td>Influenza immunization administered or previously received (hiv) (p-esrd)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>4276F</td>\n              <td>Potent antiretroviral therapy prescribed (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>4279F</td>\n              <td>Pneumocystis jiroveci pneumonia prophylaxis prescribed (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>4280F</td>\n              <td>Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count or percentage (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>4290F</td>\n              <td>Patient screened for injection drug use (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>4293F</td>\n              <td>Patient screened for high-risk sexual behavior (hiv)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>86689</td>\n              <td>Confirmation test for antibody to Human T-cell lymphotropic virus (HTLV) or HIV</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>86701</td>\n              <td>Analysis for antibody to HIV -1 virus</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>86702</td>\n              <td>Analysis for antibody to HIV-2 virus</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>86703</td>\n              <td>Analysis for antibody to HIV-1 and HIV-2 virus</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>87389</td>\n              <td>Detection test for HIV-1 and HIV-2</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>87390</td>\n              <td>Detection test for HIV-1</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>87391</td>\n              <td>Detection test for HIV-2</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>87534</td>\n              <td>Detection test for HIV-1 virus</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>87535</td>\n              <td>Detection test for HIV-1 virus</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>87536</td>\n              <td>Detection test for HIV-1 virus</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>87537</td>\n              <td>Detection test for HIV-2 virus</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>87538</td>\n              <td>Detection test for HIV-2 virus</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>87539</td>\n              <td>Detection test for HIV-2 virus</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>87900</td>\n              <td>Infectious agent drug susceptibility analysis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>87901</td>\n              <td>Analysis test for HIV-1 virus</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>87903</td>\n              <td>Analysis test for HIV-1 virus</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>87904</td>\n              <td>Analysis test for HIV-1 virus</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>87906</td>\n              <td>Analysis test for HIV-1 virus</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>G0432</td>\n              <td>Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>G0433</td>\n              <td>Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>G0435</td>\n              <td>Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>G8491</td>\n              <td>I intend to report the hiv/aids measures group</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>G8500</td>\n              <td>All quality actions for the applicable measures in the hiv/aids measures group have been performed for this patient</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>S3645</td>\n              <td>Hiv-1 antibody testing of oral mucosal transudate</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.23","version":"20160909","name":"C2S HIV/AIDS Information Sensitivity","status":"active","date":"2016-09-09T01:00:03-04:00","publisher":"SAMHSA Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","concept":[{"code":"0575F","display":"Hiv rna control plan of care, documented (hiv)"},{"code":"3292F","display":"Hiv testing ordered or documented and reviewed during the first or second prenatal visit (pre-cr)"},{"code":"3490F","display":"History of aids-defining condition (hiv)"},{"code":"3491F","display":"Hiv indeterminate (infants of undetermined hiv status born of hiv-infected mothers) (hiv)"},{"code":"3492F","display":"History of nadir cd4+ cell count <350 cells/mm (hiv)"},{"code":"3493F","display":"No history of nadir cd4+ cell count <350 cells/mmand no history of aids-defining condition (hiv)"},{"code":"3494F","display":"Cd4+ cell count <200 cells/mm (hiv)"},{"code":"3495F","display":"Cd4+ cell count 200 - 499 cells/mm (hiv)"},{"code":"3496F","display":"Cd4+ cell count =500 cells/mm (hiv)"},{"code":"3497F","display":"Cd4+ cell percentage <15% (hiv)"},{"code":"3498F","display":"Cd4+ cell percentage >/=15% (hiv)"},{"code":"3500F","display":"Cd4+ cell count or cd4+ cell percentage documented as performed (hiv)"},{"code":"3502F","display":"Hiv rna viral load below limits of quantification (hiv)"},{"code":"3503F","display":"Hiv rna viral load not below limits of quantification (hiv)"},{"code":"3510F","display":"Documentation that tuberculosis (tb) screening test performed and results interpreted (hiv) (ibd)"},{"code":"3511F","display":"Chlamydia and gonorrhea screenings documented as performed (hiv)"},{"code":"3512F","display":"Syphilis screening documented as performed (hiv)"},{"code":"3513F","display":"Hepatitis b screening documented as performed (hiv)"},{"code":"3514F","display":"Hepatitis c screening documented as performed (hiv)"},{"code":"3515F","display":"Patient has documented immunity to hepatitis c (hiv)"},{"code":"4149F","display":"Hepatitis b vaccine injection administered or previously received (hep-c, hiv) (ibd)"},{"code":"4270F","display":"Patient receiving potent antiretroviral therapy for 6 months or longer (hiv)"},{"code":"4271F","display":"Patient receiving potent antiretroviral therapy for less than 6 months or not receiving potent antiretroviral therapy (hiv)"},{"code":"4274F","display":"Influenza immunization administered or previously received (hiv) (p-esrd)"},{"code":"4276F","display":"Potent antiretroviral therapy prescribed (hiv)"},{"code":"4279F","display":"Pneumocystis jiroveci pneumonia prophylaxis prescribed (hiv)"},{"code":"4280F","display":"Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count or percentage (hiv)"},{"code":"4290F","display":"Patient screened for injection drug use (hiv)"},{"code":"4293F","display":"Patient screened for high-risk sexual behavior (hiv)"},{"code":"86689","display":"Confirmation test for antibody to Human T-cell lymphotropic virus (HTLV) or HIV"},{"code":"86701","display":"Analysis for antibody to HIV -1 virus"},{"code":"86702","display":"Analysis for antibody to HIV-2 virus"},{"code":"86703","display":"Analysis for antibody to HIV-1 and HIV-2 virus"},{"code":"87389","display":"Detection test for HIV-1 and HIV-2"},{"code":"87390","display":"Detection test for HIV-1"},{"code":"87391","display":"Detection test for HIV-2"},{"code":"87534","display":"Detection test for HIV-1 virus"},{"code":"87535","display":"Detection test for HIV-1 virus"},{"code":"87536","display":"Detection test for HIV-1 virus"},{"code":"87537","display":"Detection test for HIV-2 virus"},{"code":"87538","display":"Detection test for HIV-2 virus"},{"code":"87539","display":"Detection test for HIV-2 virus"},{"code":"87900","display":"Infectious agent drug susceptibility analysis"},{"code":"87901","display":"Analysis test for HIV-1 virus"},{"code":"87903","display":"Analysis test for HIV-1 virus"},{"code":"87904","display":"Analysis test for HIV-1 virus"},{"code":"87906","display":"Analysis test for HIV-1 virus"},{"code":"G0432","display":"Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening"},{"code":"G0433","display":"Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening"},{"code":"G0435","display":"Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening"},{"code":"G8491","display":"I intend to report the hiv/aids measures group"},{"code":"G8500","display":"All quality actions for the applicable measures in the hiv/aids measures group have been performed for this patient"},{"code":"S3645","display":"Hiv-1 antibody testing of oral mucosal transudate"}]}]}}